Previous Close | 4.7000 |
Open | 4.7000 |
Bid | 2.5000 |
Ask | 5.9000 |
Strike | 40.00 |
Expire Date | 2024-07-19 |
Day's Range | 4.7000 - 4.7000 |
Contract Range | N/A |
Volume | |
Open Interest | 2 |
On June 3, 2024, Julie Hambleton, Director at SpringWorks Therapeutics Inc (NASDAQ:SWTX), sold 4,648 shares of the company.
Badreddin Edris, the Chief Operating Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), sold 20,000 shares of the company on June 3, 2024, according to a recent SEC filing.
On June 3, 2024, Saqib Islam, the Chief Executive Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), executed a sale of 49,000 shares of the company.